Table of Content

1 Market Overview of Cannabinoid-based Antitumor Drug
1.1 Cannabinoid-based Antitumor Drug Market Overview
1.1.1 Cannabinoid-based Antitumor Drug Product Scope
1.1.2 Cannabinoid-based Antitumor Drug Market Status and Outlook
1.2 Global Cannabinoid-based Antitumor Drug Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Cannabinoid-based Antitumor Drug Market Size by Region (2024-2034)
1.4 Global Cannabinoid-based Antitumor Drug Historic Market Size by Region (2024-2024)
1.5 Global Cannabinoid-based Antitumor Drug Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Cannabinoid-based Antitumor Drug Market Size (2024-2034)
1.6.1 North America Cannabinoid-based Antitumor Drug Market Size (2024-2034)
1.6.2 Europe Cannabinoid-based Antitumor Drug Market Size (2024-2034)
1.6.3 Asia-Pacific Cannabinoid-based Antitumor Drug Market Size (2024-2034)
1.6.4 Latin America Cannabinoid-based Antitumor Drug Market Size (2024-2034)
1.6.5 Middle East & Africa Cannabinoid-based Antitumor Drug Market Size (2024-2034)
2 Cannabinoid-based Antitumor Drug Market by Type
2.1 Introduction
2.1.1 Chewing Medicine
2.1.2 Lozenge
2.1.3 Other
2.2 Global Cannabinoid-based Antitumor Drug Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Cannabinoid-based Antitumor Drug Historic Market Size by Type (2024-2024)
2.2.2 Global Cannabinoid-based Antitumor Drug Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Cannabinoid-based Antitumor Drug Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Cannabinoid-based Antitumor Drug Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Cannabinoid-based Antitumor Drug Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Cannabinoid-based Antitumor Drug Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Cannabinoid-based Antitumor Drug Revenue Breakdown by Type (2024-2034)
3 Cannabinoid-based Antitumor Drug Market Overview by Application
3.1 Introduction
3.1.1 Clinics
3.1.2 Hospitals
3.1.3 Others
3.2 Global Cannabinoid-based Antitumor Drug Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Cannabinoid-based Antitumor Drug Historic Market Size by Application (2024-2024)
3.2.2 Global Cannabinoid-based Antitumor Drug Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Cannabinoid-based Antitumor Drug Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Cannabinoid-based Antitumor Drug Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Cannabinoid-based Antitumor Drug Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Cannabinoid-based Antitumor Drug Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Cannabinoid-based Antitumor Drug Revenue Breakdown by Application (2024-2034)
4 Cannabinoid-based Antitumor Drug Competition Analysis by Players
4.1 Global Cannabinoid-based Antitumor Drug Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cannabinoid-based Antitumor Drug as of 2022)
4.3 Date of Key Players Enter into Cannabinoid-based Antitumor Drug Market
4.4 Global Top Players Cannabinoid-based Antitumor Drug Headquarters and Area Served
4.5 Key Players Cannabinoid-based Antitumor Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Cannabinoid-based Antitumor Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Cannabics Inc.
5.1.1 Cannabics Inc. Profile
5.1.2 Cannabics Inc. Main Business
5.1.3 Cannabics Inc. Cannabinoid-based Antitumor Drug Products, Services and Solutions
5.1.4 Cannabics Inc. Cannabinoid-based Antitumor Drug Revenue (US$ Million) & (2024-2024)
5.1.5 Cannabics Inc. Recent Developments
5.2 Tikun Olam
5.2.1 Tikun Olam Profile
5.2.2 Tikun Olam Main Business
5.2.3 Tikun Olam Cannabinoid-based Antitumor Drug Products, Services and Solutions
5.2.4 Tikun Olam Cannabinoid-based Antitumor Drug Revenue (US$ Million) & (2024-2024)
5.2.5 Tikun Olam Recent Developments
5.3 Jay Pharma
5.3.1 Jay Pharma Profile
5.3.2 Jay Pharma Main Business
5.3.3 Jay Pharma Cannabinoid-based Antitumor Drug Products, Services and Solutions
5.3.4 Jay Pharma Cannabinoid-based Antitumor Drug Revenue (US$ Million) & (2024-2024)
5.3.5 GW Pharmaceuticals Recent Developments
5.4 GW Pharmaceuticals
5.4.1 GW Pharmaceuticals Profile
5.4.2 GW Pharmaceuticals Main Business
5.4.3 GW Pharmaceuticals Cannabinoid-based Antitumor Drug Products, Services and Solutions
5.4.4 GW Pharmaceuticals Cannabinoid-based Antitumor Drug Revenue (US$ Million) & (2024-2024)
5.4.5 GW Pharmaceuticals Recent Developments
5.5 Medicanja Ltd
5.5.1 Medicanja Ltd Profile
5.5.2 Medicanja Ltd Main Business
5.5.3 Medicanja Ltd Cannabinoid-based Antitumor Drug Products, Services and Solutions
5.5.4 Medicanja Ltd Cannabinoid-based Antitumor Drug Revenue (US$ Million) & (2024-2024)
5.5.5 Medicanja Ltd Recent Developments
5.6 Valeant Pharmaceuticals
5.6.1 Valeant Pharmaceuticals Profile
5.6.2 Valeant Pharmaceuticals Main Business
5.6.3 Valeant Pharmaceuticals Cannabinoid-based Antitumor Drug Products, Services and Solutions
5.6.4 Valeant Pharmaceuticals Cannabinoid-based Antitumor Drug Revenue (US$ Million) & (2024-2024)
5.6.5 Valeant Pharmaceuticals Recent Developments
6 North America
6.1 North America Cannabinoid-based Antitumor Drug Market Size by Country (2024-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Cannabinoid-based Antitumor Drug Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cannabinoid-based Antitumor Drug Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cannabinoid-based Antitumor Drug Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cannabinoid-based Antitumor Drug Market Dynamics
11.1 Cannabinoid-based Antitumor Drug Industry Trends
11.2 Cannabinoid-based Antitumor Drug Market Drivers
11.3 Cannabinoid-based Antitumor Drug Market Challenges
11.4 Cannabinoid-based Antitumor Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Cannabinoid-based Antitumor Drug Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Cannabinoid-based Antitumor Drug Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Cannabinoid-based Antitumor Drug Market Size Share by Region (2024-2024)
Table 4. Global Cannabinoid-based Antitumor Drug Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Cannabinoid-based Antitumor Drug Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Cannabinoid-based Antitumor Drug Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Cannabinoid-based Antitumor Drug Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Cannabinoid-based Antitumor Drug Revenue Market Share by Type (2024-2024)
Table 9. Global Cannabinoid-based Antitumor Drug Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Cannabinoid-based Antitumor Drug Revenue Market Share by Type (2024-2034)
Table 11. North America Cannabinoid-based Antitumor Drug Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Cannabinoid-based Antitumor Drug Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Cannabinoid-based Antitumor Drug Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Cannabinoid-based Antitumor Drug Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Cannabinoid-based Antitumor Drug Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Cannabinoid-based Antitumor Drug Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Cannabinoid-based Antitumor Drug Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Cannabinoid-based Antitumor Drug Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Cannabinoid-based Antitumor Drug Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Cannabinoid-based Antitumor Drug Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Cannabinoid-based Antitumor Drug Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Cannabinoid-based Antitumor Drug Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Cannabinoid-based Antitumor Drug Revenue Market Share by Application (2024-2024)
Table 24. Global Cannabinoid-based Antitumor Drug Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Cannabinoid-based Antitumor Drug Revenue Market Share by Application (2024-2034)
Table 26. North America Cannabinoid-based Antitumor Drug Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Cannabinoid-based Antitumor Drug Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Cannabinoid-based Antitumor Drug Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Cannabinoid-based Antitumor Drug Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Cannabinoid-based Antitumor Drug Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Cannabinoid-based Antitumor Drug Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Cannabinoid-based Antitumor Drug Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Cannabinoid-based Antitumor Drug Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Cannabinoid-based Antitumor Drug Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Cannabinoid-based Antitumor Drug Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Cannabinoid-based Antitumor Drug Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Cannabinoid-based Antitumor Drug Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cannabinoid-based Antitumor Drug as of 2022)
Table 39. Date of Key Players Enter into Cannabinoid-based Antitumor Drug Market
Table 40. Global Cannabinoid-based Antitumor Drug Key Players Headquarters and Area Served
Table 41. Cannabinoid-based Antitumor Drug Product Solution and Service
Table 42. Global Cannabinoid-based Antitumor Drug Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Cannabics Inc. Basic Information List
Table 45. Cannabics Inc. Description and Business Overview
Table 46. Cannabics Inc. Cannabinoid-based Antitumor Drug Products, Services and Solutions
Table 47. Revenue (US$ Million) in Cannabinoid-based Antitumor Drug Business of Cannabics Inc. (2024-2024)
Table 48. Cannabics Inc. Recent Developments
Table 49. Tikun Olam Basic Information List
Table 50. Tikun Olam Description and Business Overview
Table 51. Tikun Olam Cannabinoid-based Antitumor Drug Products, Services and Solutions
Table 52. Revenue (US$ Million) in Cannabinoid-based Antitumor Drug Business of Tikun Olam (2024-2024)
Table 53. Tikun Olam Recent Developments
Table 54. Jay Pharma Basic Information List
Table 55. Jay Pharma Description and Business Overview
Table 56. Jay Pharma Cannabinoid-based Antitumor Drug Products, Services and Solutions
Table 57. Revenue (US$ Million) in Cannabinoid-based Antitumor Drug Business of Jay Pharma (2024-2024)
Table 58. Jay Pharma Recent Developments
Table 59. GW Pharmaceuticals Basic Information List
Table 60. GW Pharmaceuticals Description and Business Overview
Table 61. GW Pharmaceuticals Cannabinoid-based Antitumor Drug Products, Services and Solutions
Table 62. Revenue (US$ Million) in Cannabinoid-based Antitumor Drug Business of GW Pharmaceuticals (2024-2024)
Table 63. GW Pharmaceuticals Recent Developments
Table 64. Medicanja Ltd Basic Information List
Table 65. Medicanja Ltd Description and Business Overview
Table 66. Medicanja Ltd Cannabinoid-based Antitumor Drug Products, Services and Solutions
Table 67. Revenue (US$ Million) in Cannabinoid-based Antitumor Drug Business of Medicanja Ltd (2024-2024)
Table 68. Medicanja Ltd Recent Developments
Table 69. Valeant Pharmaceuticals Basic Information List
Table 70. Valeant Pharmaceuticals Description and Business Overview
Table 71. Valeant Pharmaceuticals Cannabinoid-based Antitumor Drug Products, Services and Solutions
Table 72. Revenue (US$ Million) in Cannabinoid-based Antitumor Drug Business of Valeant Pharmaceuticals (2024-2024)
Table 73. Valeant Pharmaceuticals Recent Developments
Table 74. North America Cannabinoid-based Antitumor Drug Market Size by Country (2024-2024) & (US$ Million)
Table 75. North America Cannabinoid-based Antitumor Drug Market Size by Country (2024-2034) & (US$ Million)
Table 76. Europe Cannabinoid-based Antitumor Drug Market Size by Country (2024-2024) & (US$ Million)
Table 77. Europe Cannabinoid-based Antitumor Drug Market Size by Country (2024-2034) & (US$ Million)
Table 78. Asia-Pacific Cannabinoid-based Antitumor Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 79. Asia-Pacific Cannabinoid-based Antitumor Drug Market Size by Region (2024-2024) & (US$ Million)
Table 80. Asia-Pacific Cannabinoid-based Antitumor Drug Market Size by Region (2024-2034) & (US$ Million)
Table 81. Asia-Pacific Cannabinoid-based Antitumor Drug Market Share by Region (2024-2024)
Table 82. Asia-Pacific Cannabinoid-based Antitumor Drug Market Share by Region (2024-2034)
Table 83. Latin America Cannabinoid-based Antitumor Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 84. Latin America Cannabinoid-based Antitumor Drug Market Size by Country (2024-2024) & (US$ Million)
Table 85. Latin America Cannabinoid-based Antitumor Drug Market Size by Country (2024-2034) & (US$ Million)
Table 86. Middle East & Africa Cannabinoid-based Antitumor Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 87. Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Country (2024-2024) & (US$ Million)
Table 88. Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Country (2024-2034) & (US$ Million)
Table 89. Cannabinoid-based Antitumor Drug Market Trends
Table 90. Cannabinoid-based Antitumor Drug Market Drivers
Table 91. Cannabinoid-based Antitumor Drug Market Challenges
Table 92. Cannabinoid-based Antitumor Drug Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cannabinoid-based Antitumor Drug Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Cannabinoid-based Antitumor Drug Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Cannabinoid-based Antitumor Drug Market Share by Regions: 2022 VS 2034
Figure 4. Global Cannabinoid-based Antitumor Drug Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Cannabinoid-based Antitumor Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Cannabinoid-based Antitumor Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Cannabinoid-based Antitumor Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Cannabinoid-based Antitumor Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Cannabinoid-based Antitumor Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Chewing Medicine
Figure 11. Global Chewing Medicine Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Lozenge
Figure 13. Global Lozenge Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Other
Figure 15. Global Other Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Global Cannabinoid-based Antitumor Drug Market Size Share by Type: 2022 & 2034
Figure 17. North America Cannabinoid-based Antitumor Drug Revenue Market Share by Type (2024-2034)
Figure 18. Europe Cannabinoid-based Antitumor Drug Revenue Market Share by Type (2024-2034)
Figure 19. Asia-Pacific Cannabinoid-based Antitumor Drug Revenue Market Share by Type (2024-2034)
Figure 20. Latin America Cannabinoid-based Antitumor Drug Revenue Market Share by Type (2024-2034)
Figure 21. Middle East and Africa Cannabinoid-based Antitumor Drug Revenue Market Share by Type (2024-2034)
Figure 22. Clinics Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Hospitals Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Global Cannabinoid-based Antitumor Drug Market Size Share by Application: 2022 & 2034
Figure 26. North America Cannabinoid-based Antitumor Drug Revenue Market Share by Application (2024-2034)
Figure 27. Europe Cannabinoid-based Antitumor Drug Revenue Market Share by Application (2024-2034)
Figure 28. Asia-Pacific Cannabinoid-based Antitumor Drug Revenue Market Share by Application (2024-2034)
Figure 29. Latin America Cannabinoid-based Antitumor Drug Revenue Market Share by Application (2024-2034)
Figure 30. Middle East and Africa Cannabinoid-based Antitumor Drug Revenue Market Share by Application (2024-2034)
Figure 31. Cannabinoid-based Antitumor Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 32. Global Top 5 and Top 10 Players Cannabinoid-based Antitumor Drug Market Share in 2022
Figure 33. North America Cannabinoid-based Antitumor Drug Market Share by Country (2024-2034)
Figure 34. United States Cannabinoid-based Antitumor Drug Market Size (2024-2034) & (US$ Million)
Figure 35. Canada Cannabinoid-based Antitumor Drug Market Size (2024-2034) & (US$ Million)
Figure 36. Germany Cannabinoid-based Antitumor Drug Market Size (2024-2034) & (US$ Million)
Figure 37. France Cannabinoid-based Antitumor Drug Market Size (2024-2034) & (US$ Million)
Figure 38. U.K. Cannabinoid-based Antitumor Drug Market Size (2024-2034) & (US$ Million)
Figure 39. Italy Cannabinoid-based Antitumor Drug Market Size (2024-2034) & (US$ Million)
Figure 40. Russia Cannabinoid-based Antitumor Drug Market Size (2024-2034) & (US$ Million)
Figure 41. Nordic Countries Cannabinoid-based Antitumor Drug Market Size (2024-2034) & (US$ Million)
Figure 42. Asia-Pacific Cannabinoid-based Antitumor Drug Market Share by Region (2024-2034)
Figure 43. China Cannabinoid-based Antitumor Drug Market Size (2024-2034) & (US$ Million)
Figure 44. Japan Cannabinoid-based Antitumor Drug Market Size (2024-2034) & (US$ Million)
Figure 45. South Korea Cannabinoid-based Antitumor Drug Market Size (2024-2034) & (US$ Million)
Figure 46. Southeast Asia Cannabinoid-based Antitumor Drug Market Size (2024-2034) & (US$ Million)
Figure 47. India Cannabinoid-based Antitumor Drug Market Size (2024-2034) & (US$ Million)
Figure 48. Australia Cannabinoid-based Antitumor Drug Market Size (2024-2034) & (US$ Million)
Figure 49. Latin America Cannabinoid-based Antitumor Drug Market Share by Country (2024-2034)
Figure 50. Mexico Cannabinoid-based Antitumor Drug Market Size (2024-2034) & (US$ Million)
Figure 51. Brazil Cannabinoid-based Antitumor Drug Market Size (2024-2034) & (US$ Million)
Figure 52. Middle East & Africa Cannabinoid-based Antitumor Drug Market Share by Country (2024-2034)
Figure 53. Turkey Cannabinoid-based Antitumor Drug Market Size (2024-2034) & (US$ Million)
Figure 54. Saudi Arabia Cannabinoid-based Antitumor Drug Market Size (2024-2034) & (US$ Million)
Figure 55. UAE Cannabinoid-based Antitumor Drug Market Size (2024-2034) & (US$ Million)
Figure 56. Bottom-up and Top-down Approaches for This Report